European consultants to cooperate:
This article was originally published in Clinica
European Medical Device Consultants (Switzerland) and d-Target (Netherlands) are to cooperate more closely in providing services to clients. The companies will not merge, as stated in Clinica No 830, p 7. The newly established QualiTeam Group will offer services for CE-marking and premarket approvals outside Europe, as well as post-market compliance support anywhere in the world.
You may also be interested in...
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.